Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' DEFICIT (Tables)

v3.4.0.3
STOCKHOLDERS' DEFICIT (Tables)
 6 Months Ended
Mar. 31, 2016
Stockholders' Equity Note [Abstract]  
Schedule of stock-based compensation expense

Stock-based compensation expense included in the accompanying statements of operations for the three and six months ended March 31, 2016 and 2015 is as follows:   

 

   

For the three months ended

March 31,

  
    2016     2015  
Research     10,400       10,400  
Product Development     7,700       15,500  
Sales and marketing     14,900       53,400  
General and administrative     7,200       20,500  
Total   $ 40,200     $ 99,800  

  

   

For the six months ended

March 31,

  
    2016     2015  
Research     20,800       20,800  
Product Development     16,800       34,000  
Sales and marketing     14,900       63,300  
General and administrative     18,400       44,100  
Total   $ 70,900     $ 162,200  
Schedule of stock option activity

A summary of stock option activity is as follows: 

 

   

Number of 

Shares

    

Weighted

Average 

Exercise 

Price

  
Outstanding at September 30, 2015     14,230,011     $ 0.75  
Granted     -          
Exercised     -       -  
Forfeited     -          
Outstanding at March 31, 2016     14,230,011     $ 0.75  
Schedule of the status of options outstanding

Following is a summary of the status of options outstanding at March 31, 2016:

  

Exercise

Price ($)

    

Number

of Shares

    

Expiration

Date

  

Weighted Average

Exercise Price ($)

  
                   
$ 0.055       1,750,000     08/2025   $ 0.055  
  0.04718       8,795,308     12/2022 – 01/2023     0.04718  
  0.25       2,715,109     03/2023 – 01/2025     0.25  
  0.26       425,000     07/2024     0.26  
  3.00       42,670     03/2022     3.00  
  3.60       28,648     08/2016     3.60  
  3.96       32,928     08/2016     3.96  
  9.00       4,525     11/2016     9.00  
  12.00       28,535     03/2019 – 07/2020     12.00  
  14.10       10,000     03/2021     14.10  
  15.30       1,373     09/2018     15.30  
  16.50       262,441     03/2020     16.50  
  17.70       953     08/2016     17.70  
  24.00       4,667     12/2017     24.00  
  26.70       32,297     09/2017     26.70  
  28.80       11,767     04/2018     28.80  
  32.70       83,790     08/2017     32.70  
$ Total       14,230,011     Average   $ 0.75  
Schedule of share-based compensation warrants

 The warrant activity for the period starting October 1, 2015, through March 31, 2016, is described as follows:

 

   

Number of 

Shares

    

Weighted

Average 

Exercise Price

  
Outstanding at September 30, 2015     781,524     $ 0.53  
Granted     87,200,000       0.05  
Exercised     -       -  
Expired     (35,002 )     1.00  
Outstanding at March 31, 2016     87,946,522     $ 0.05
Schedule of the status of warrants outstanding

Following is a summary of the status of warrants outstanding at March 31, 2016:

 

Exercise

Price

    

Number

of Shares

    

Expiration

Date

  

Weighted Average

Exercise Price

  
                         
$ 0.04718       38,152     03/2018   $ 0.04718  
  0.05       27,200,000 (1)   12/31/2020     0.05  
  0.05       60,000,000 (2)   12/31/2020     0.05  
  0.25       332,200     04/2016 – 07/2017     0.25  
  0.275       324,000     06/2018 – 03/2019     0.275  
  1.00       32,168     10/2015 – 01/2017     1.00  
  7.50       3,334     05/2016     7.50  
$ 9.00       16,668     07/2017     9.00  
  Total       87,946,522         $ 0.05  
Schedule of black-scholes option-pricing model assumption inputs

 The range of Black-Scholes option-pricing model assumption inputs for the six months ended March 31, 2016, were as follows: 

 

    December 23, 2015
through
March 31,2016		  
Annual dividend yield     -  
Expected life (years)     5.00  
Risk-free interest rate     1.21% ~ 1.74 %  
Expected volatility     255.50% ~ 272.56 %